Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 116

1.

Integrating Clinical Ultrasound Into Screening for Cystic Fibrosis Liver Disease: Approach With Caution and Optimism.

Narkewicz MR.

J Pediatr Gastroenterol Nutr. 2019 Oct;69(4):394-395. doi: 10.1097/MPG.0000000000002441. No abstract available.

PMID:
31436709
2.

Liver Ultrasound Patterns in Children With Cystic Fibrosis Correlate With Noninvasive Tests of Liver Disease.

Ling SC, Ye W, Leung DH, Navarro OM, Weymann A, Karnsakul W, Freeman AJ, Magee JC, Narkewicz MR.

J Pediatr Gastroenterol Nutr. 2019 Sep;69(3):351-357. doi: 10.1097/MPG.0000000000002413.

PMID:
31436672
3.

Ledipasvir-Sofosbuvir for 12 Weeks in Children 3 to <6 Years Old With Chronic Hepatitis C.

Schwarz KB, Rosenthal P, Murray KF, Honegger JR, Hardikar W, Hague R, Mittal N, Massetto B, Brainard DM, Hsueh CH, Shao J, Parhy B, Narkewicz MR, Rao GS, Whitworth S, Bansal S, Balistreri WF.

Hepatology. 2019 Jun 20. doi: 10.1002/hep.30830. [Epub ahead of print]

PMID:
31220349
4.

A Multidisciplinary Approach to Pretransplant and Posttransplant Management of Cystic Fibrosis-Associated Liver Disease.

Freeman AJ, Sellers ZM, Mazariegos G, Kelly A, Saiman L, Mallory G, Ling SC, Narkewicz MR, Leung DH.

Liver Transpl. 2019 Apr;25(4):640-657. doi: 10.1002/lt.25421. Epub 2019 Mar 20.

PMID:
30697907
5.

Ombitasvir/Paritaprevir/Ritonavir With or Without Dasabuvir and With or Without Ribavirin for Adolescents With HCV Genotype 1 or 4.

Leung DH, Wirth S, Yao BB, Viani RM, Gonzalez-Peralta RP, Jonas MM, Lobritto SJ, Narkewicz MR, Sokal E, Fortuny C, Hsu EK, Del Valle-Segarra A, Zha J, Larsen L, Liu L, Shuster DL, Cohen DE, Rosenthal P.

Hepatol Commun. 2018 Oct 5;2(11):1311-1319. doi: 10.1002/hep4.1250. eCollection 2018 Nov.

6.

Safety and Efficacy of Ledipasvir-Sofosbuvir With or Without Ribavirin for Chronic Hepatitis C in Children Ages 6-11.

Murray KF, Balistreri WF, Bansal S, Whitworth S, Evans HM, Gonzalez-Peralta RP, Wen J, Massetto B, Kersey K, Shao J, Garrison KL, Parhy B, Brainard DM, Arnon R, Gillis LA, Jonas MM, Lin CH, Narkewicz MR, Schwarz K, Rosenthal P.

Hepatology. 2018 Dec;68(6):2158-2166. doi: 10.1002/hep.30123. Epub 2018 Nov 17.

PMID:
30070726
7.

Approach and Safety of Esophageal Dilation for Treatment of Strictures in Children With Epidermolysis Bullosa.

Anderson BT, Feinstein JA, Kramer RE, Narkewicz MR, Bruckner AL, Brumbaugh DE.

J Pediatr Gastroenterol Nutr. 2018 Dec;67(6):701-705. doi: 10.1097/MPG.0000000000002106.

8.

Pulmonary Screening in Subjects after the Fontan Procedure.

Liptzin DR, Di Maria MV, Younoszai A, Narkewicz MR, Kelly SL, Wolfe KR, Veress LA.

J Pediatr. 2018 Aug;199:140-143. doi: 10.1016/j.jpeds.2018.03.050. Epub 2018 May 7.

PMID:
29747936
9.

A Learning Collaborative Approach Increases Specificity of Diagnosis of Acute Liver Failure in Pediatric Patients.

Narkewicz MR, Horslen S, Hardison RM, Shneider BL, Rodriguez-Baez N, Alonso EM, Ng VL, Leonis MA, Loomes KM, Rudnick DA, Rosenthal P, Romero R, Subbarao GC, Li R, Belle SH, Squires RH; Pediatric Acute Liver Failure Study Group.

Clin Gastroenterol Hepatol. 2018 Nov;16(11):1801-1810.e3. doi: 10.1016/j.cgh.2018.04.050. Epub 2018 Apr 30.

10.

Cutting-edge Treatment for Benign Pediatric Esophageal Strictures, a Step Forward, More to Go.

Mark J, Narkewicz MR.

J Pediatr Gastroenterol Nutr. 2018 Oct;67(4):433-434. doi: 10.1097/MPG.0000000000002009. No abstract available.

PMID:
29697551
11.

Acoustic radiation force impulse of the liver after Fontan operation: Correlation with cardiopulmonary exercise test.

Di Maria MV, Silverman L, Younoszai AK, Meyers ML, Capocelli KE, Narkewicz MR.

Congenit Heart Dis. 2018 May;13(3):444-449. doi: 10.1111/chd.12594. Epub 2018 Feb 23.

PMID:
29473337
12.

Cystic Fibrosis-related cirrhosis.

Leung DH, Narkewicz MR.

J Cyst Fibros. 2017 Nov;16 Suppl 2:S50-S61. doi: 10.1016/j.jcf.2017.07.002. Review.

13.

Variceal Hemorrhage and Adverse Liver Outcomes in Patients With Cystic Fibrosis Cirrhosis.

Ye W, Narkewicz MR, Leung DH, Karnsakul W, Murray KF, Alonso EM, Magee JC, Schwarzenberg SJ, Weymann A, Molleston JP; CFLDnet research group.

J Pediatr Gastroenterol Nutr. 2018 Jan;66(1):122-127. doi: 10.1097/MPG.0000000000001728.

14.

Cystic Fibrosis-related Liver Disease: Research Challenges and Future Perspectives.

Debray D, Narkewicz MR, Bodewes FAJA, Colombo C, Housset C, de Jonge HR, Jonker JW, Kelly DA, Ling SC, Poynard T, Sogni P, Trauner M, Witters P, Baumann U, Wilschanski M, Verkade HJ.

J Pediatr Gastroenterol Nutr. 2017 Oct;65(4):443-448. doi: 10.1097/MPG.0000000000001676.

PMID:
28753176
15.

Lactate and Lactate: Pyruvate Ratio in the Diagnosis and Outcomes of Pediatric Acute Liver Failure.

Feldman AG, Sokol RJ, Hardison RM, Alonso EM, Squires RH, Narkewicz MR; Pediatric Acute Liver Failure Study Group.

J Pediatr. 2017 Mar;182:217-222.e3. doi: 10.1016/j.jpeds.2016.12.031. Epub 2017 Jan 12.

16.

The CF gastrointestinal microbiome: Structure and clinical impact.

Rogers GB, Narkewicz MR, Hoffman LR.

Pediatr Pulmonol. 2016 Oct;51(S44):S35-S44. doi: 10.1002/ppul.23544. Review.

17.

Prevalence of elevated liver enzymes in children with cystic fibrosis diagnosed by newborn screen.

Woodruff SA, Sontag MK, Accurso FJ, Sokol RJ, Narkewicz MR.

J Cyst Fibros. 2017 Jan;16(1):139-145. doi: 10.1016/j.jcf.2016.08.002. Epub 2016 Aug 20.

18.

Prevalence and Significance of Autoantibodies in Children With Acute Liver Failure.

Narkewicz MR, Horslen S, Belle SH, Rudnick DA, Ng VL, Rosenthal P, Romero R, Loomes KM, Zhang S, Hardison RM, Squires RH; Pediatric Acute Liver Failure Study Group.

J Pediatr Gastroenterol Nutr. 2017 Feb;64(2):210-217. doi: 10.1097/MPG.0000000000001363.

19.

Cystic Fibrosis Liver Disease and Ursodeoxycholic Acid: One Small Step Forward, Miles to Go.

Narkewicz MR.

J Pediatr. 2016 Oct;177:17-18. doi: 10.1016/j.jpeds.2016.06.020. Epub 2016 Jul 14. No abstract available.

PMID:
27423176
20.

CD4+ and CD8+ T Cell Activation in Children with Hepatitis C.

Sheiko MA, Golden-Mason L, Giugliano S, Hurtado CW, Mack CL, Narkewicz MR, Rosen HR.

J Pediatr. 2016 Mar;170:142-8.e1. doi: 10.1016/j.jpeds.2015.11.055. Epub 2015 Dec 30.

21.

Total Serum Bilirubin within 3 Months of Hepatoportoenterostomy Predicts Short-Term Outcomes in Biliary Atresia.

Shneider BL, Magee JC, Karpen SJ, Rand EB, Narkewicz MR, Bass LM, Schwarz K, Whitington PF, Bezerra JA, Kerkar N, Haber B, Rosenthal P, Turmelle YP, Molleston JP, Murray KF, Ng VL, Wang KS, Romero R, Squires RH, Arnon R, Sherker AH, Moore J, Ye W, Sokol RJ; Childhood Liver Disease Research Network (ChiLDReN).

J Pediatr. 2016 Mar;170:211-7.e1-2. doi: 10.1016/j.jpeds.2015.11.058. Epub 2015 Dec 24.

22.

Genetic Mutations in Pediatric Pancreatitis.

Vue PM, McFann K, Narkewicz MR.

Pancreas. 2016 Aug;45(7):992-6. doi: 10.1097/MPA.0000000000000589.

PMID:
26692446
23.

Adverse Events Following Gastrointestinal Endoscopy in Children: Classifications, Characterizations, and Implications.

Kramer RE, Narkewicz MR.

J Pediatr Gastroenterol Nutr. 2016 Jun;62(6):828-33. doi: 10.1097/MPG.0000000000001038.

PMID:
26594830
24.

Baseline Ultrasound and Clinical Correlates in Children with Cystic Fibrosis.

Leung DH, Ye W, Molleston JP, Weymann A, Ling S, Paranjape SM, Romero R, Schwarzenberg SJ, Palermo J, Alonso EM, Murray KF, Marshall BC, Sherker AH, Siegel MJ, Krishnamurthy R, Harned R, Karmazyn B, Magee JC, Narkewicz MR; Cystic Fibrosis Liver Disease Network (CFLD NET).

J Pediatr. 2015 Oct;167(4):862-868.e2. doi: 10.1016/j.jpeds.2015.06.062. Epub 2015 Aug 5.

25.

Intestinal lesions are associated with altered intestinal microbiome and are more frequent in children and young adults with cystic fibrosis and cirrhosis.

Flass T, Tong S, Frank DN, Wagner BD, Robertson CE, Kotter CV, Sokol RJ, Zemanick E, Accurso F, Hoffenberg EJ, Narkewicz MR.

PLoS One. 2015 Feb 6;10(2):e0116967. doi: 10.1371/journal.pone.0116967. eCollection 2015.

26.

GiECAT(KIDS) validated pediatric colonoscopy assessment tool: a call to action.

Sauer CG, Narkewicz MR.

J Pediatr Gastroenterol Nutr. 2015 Apr;60(4):425-7. doi: 10.1097/MPG.0000000000000728. No abstract available.

PMID:
25611036
27.

Preoperative imaging does not predict intrahepatic involvement in choledochal cysts.

Acker SN, Bruny JL, Narkewicz MR, Roach JP, Rogers A, Karrer FM.

J Pediatr Surg. 2013 Dec;48(12):2378-82. doi: 10.1016/j.jpedsurg.2013.08.008.

PMID:
24314174
28.

Evaluating progression of liver disease from repeat liver biopsies in children with chronic hepatitis C: a retrospective study.

Mohan P, Barton BA, Narkewicz MR, Molleston JP, Gonzalez-Peralta RP, Rosenthal P, Murray KF, Haber B, Schwarz KB, Goodman ZD.

Hepatology. 2013 Nov;58(5):1580-6. doi: 10.1002/hep.26519. Epub 2013 Sep 30.

29.

Decreasing incidence of symptomatic Epstein-Barr virus disease and posttransplant lymphoproliferative disorder in pediatric liver transplant recipients: report of the studies of pediatric liver transplantation experience.

Narkewicz MR, Green M, Dunn S, Millis M, McDiarmid S, Mazariegos G, Anand R, Yin W; Studies of Pediatric Liver Transplantation Research Group.

Liver Transpl. 2013 Jul;19(7):730-40. doi: 10.1002/lt.23659.

30.

Autoantibodies and autoimmune disease during treatment of children with chronic hepatitis C.

Molleston JP, Mellman W, Narkewicz MR, Balistreri WF, Gonzalez-Peralta RP, Jonas MM, Lobritto SJ, Mohan P, Murray KF, Njoku D, Rosenthal P, Barton BA, Talor MV, Cheng I, Schwarz KB, Haber BA; PEDS-C Clinical Research Network.

J Pediatr Gastroenterol Nutr. 2013 Mar;56(3):304-10. doi: 10.1097/MPG.0b013e3182774cae.

31.

NASPGHAN guidelines for training in pediatric gastroenterology.

Leichtner AM, Gillis LA, Gupta S, Heubi J, Kay M, Narkewicz MR, Rider EA, Rufo PA, Sferra TJ, Teitelbaum J; NASPGHAN Training Committee; North American Society for Pediatric Gastroenterology.

J Pediatr Gastroenterol Nutr. 2013 Jan;56 Suppl 1:S1-8. doi: 10.1097/MPG.0b013e31827a78d6. No abstract available.

PMID:
23263531
32.

Cirrhosis and other liver disease in cystic fibrosis.

Flass T, Narkewicz MR.

J Cyst Fibros. 2013 Mar;12(2):116-24. doi: 10.1016/j.jcf.2012.11.010. Epub 2012 Dec 20. Review. No abstract available.

33.

Evaluation of the liver injury unit scoring system to predict survival in a multinational study of pediatric acute liver failure.

Lu BR, Zhang S, Narkewicz MR, Belle SH, Squires RH, Sokol RJ; Pediatric Acute Liver Failure Study Group.

J Pediatr. 2013 May;162(5):1010-6.e1-4. doi: 10.1016/j.jpeds.2012.11.021. Epub 2012 Dec 20.

34.

Incidence and clinical significance of elevated liver function tests in cystic fibrosis clinical trials.

Mayer-Hamblett N, Kloster M, Ramsey BW, Narkewicz MR, Saiman L, Goss CH.

Contemp Clin Trials. 2013 Mar;34(2):232-8. doi: 10.1016/j.cct.2012.11.005. Epub 2012 Nov 29.

35.

Immunophenotype predicts outcome in pediatric acute liver failure.

Bucuvalas J, Filipovich L, Yazigi N, Narkewicz MR, Ng V, Belle SH, Zhang S, Squires RH.

J Pediatr Gastroenterol Nutr. 2013 Mar;56(3):311-5. doi: 10.1097/MPG.0b013e31827a78b2.

36.

Intravenous N-acetylcysteine in pediatric patients with nonacetaminophen acute liver failure: a placebo-controlled clinical trial.

Squires RH, Dhawan A, Alonso E, Narkewicz MR, Shneider BL, Rodriguez-Baez N, Olio DD, Karpen S, Bucuvalas J, Lobritto S, Rand E, Rosenthal P, Horslen S, Ng V, Subbarao G, Kerkar N, Rudnick D, Lopez MJ, Schwarz K, Romero R, Elisofon S, Doo E, Robuck PR, Lawlor S, Belle SH; Pediatric Acute Liver Failure Study Group.

Hepatology. 2013 Apr;57(4):1542-9. doi: 10.1002/hep.26001. Epub 2013 Feb 4.

37.

Heavy breathing: a step to noninvasive assessment of hepatic fibrosis and function in infants and children.

Narkewicz MR.

J Pediatr Gastroenterol Nutr. 2013 Jan;56(1):2. doi: 10.1097/MPG.0b013e31826abe97. No abstract available.

PMID:
22847465
38.

NASPGHAN practice guidelines: Diagnosis and management of hepatitis C infection in infants, children, and adolescents.

Mack CL, Gonzalez-Peralta RP, Gupta N, Leung D, Narkewicz MR, Roberts EA, Rosenthal P, Schwarz KB; North American Society for Pediatric Gastroenterology, Hepatology, and Nutrition.

J Pediatr Gastroenterol Nutr. 2012 Jun;54(6):838-55. doi: 10.1097/MPG.0b013e318258328d.

PMID:
22487950
39.

Durability of sustained response shown in paediatric patients with chronic hepatitis C who were treated with interferon alfa-2b plus ribavirin.

Kelly DA, Haber B, González-Peralta RP, Murray KF, Jonas MM, Molleston JP, Narkewicz MR, Sinatra FR, Lang T, Lachaux A, Wirth S, Shelton M, Te HS, Pollack H, Deng W, Noviello S, Albrecht JK.

J Viral Hepat. 2012 Apr;19(4):263-70. doi: 10.1111/j.1365-2893.2011.01544.x. Epub 2011 Nov 17.

PMID:
22404724
40.

Pegylated interferon for chronic hepatitis C in children affects growth and body composition: results from the pediatric study of hepatitis C (PEDS-C) trial.

Jonas MM, Balistreri W, Gonzalez-Peralta RP, Haber B, Lobritto S, Mohan P, Molleston JP, Murray KF, Narkewicz MR, Rosenthal P, Schwarz KB, Barton BA, Shepherd JA, Mitchell PD, Duggan C.

Hepatology. 2012 Aug;56(2):523-31. doi: 10.1002/hep.25690. Epub 2012 Jul 6.

41.

Pulmonary function in individuals who underwent liver transplantation: from the US cystic fibrosis foundation registry.

Miller MR, Sokol RJ, Narkewicz MR, Sontag MK.

Liver Transpl. 2012 May;18(5):585-93. doi: 10.1002/lt.23389.

42.

Characterization and outcomes of young infants with acute liver failure.

Sundaram SS, Alonso EM, Narkewicz MR, Zhang S, Squires RH; Pediatric Acute Liver Failure Study Group.

J Pediatr. 2011 Nov;159(5):813-818.e1. doi: 10.1016/j.jpeds.2011.04.016. Epub 2011 May 31.

43.

Peginterferon with or without ribavirin has minimal effect on quality of life, behavioral/emotional, and cognitive outcomes in children.

Rodrigue JR, Balistreri W, Haber B, Jonas MM, Mohan P, Molleston JP, Murray KF, Narkewicz MR, Rosenthal P, Smith LJ, Lobritto SJ, Schwarz KB, Robuck PR, Barton B, González-Peralta RP.

Hepatology. 2011 May;53(5):1468-75. doi: 10.1002/hep.24248.

44.

Choledochoduodenostomy in pediatric liver transplantation.

Campsen J, Zimmerman MA, Narkewicz MR, Sokol RJ, Mandell MS, Kam I, Dovel D, Karrer FM.

Pediatr Transplant. 2011 May;15(3):237-9. doi: 10.1111/j.1399-3046.2010.01338.x. Epub 2011 Jan 9.

PMID:
21214697
45.

The combination of ribavirin and peginterferon is superior to peginterferon and placebo for children and adolescents with chronic hepatitis C.

Schwarz KB, Gonzalez-Peralta RP, Murray KF, Molleston JP, Haber BA, Jonas MM, Rosenthal P, Mohan P, Balistreri WF, Narkewicz MR, Smith L, Lobritto SJ, Rossi S, Valsamakis A, Goodman Z, Robuck PR, Barton BA; Peds-C Clinical Research Network.

Gastroenterology. 2011 Feb;140(2):450-458.e1. doi: 10.1053/j.gastro.2010.10.047. Epub 2010 Oct 28.

46.

Laparoscopic suture rectopexy for full-thickness anorectal prolapse in children: an effective outpatient procedure.

Potter DD, Bruny JL, Allshouse MJ, Narkewicz MR, Soden JS, Partrick DA.

J Pediatr Surg. 2010 Oct;45(10):2103-7. doi: 10.1016/j.jpedsurg.2010.06.006.

PMID:
20920740
47.

Treatment of children with chronic hepatitis B virus infection in the United States: patient selection and therapeutic options.

Jonas MM, Block JM, Haber BA, Karpen SJ, London WT, Murray KF, Narkewicz MR, Rosenthal P, Schwarz KB, McMahon BJ; Hepatitis B Foundation.

Hepatology. 2010 Dec;52(6):2192-205. doi: 10.1002/hep.23934. Epub 2010 Oct 1.

PMID:
20890947
48.

Innate immune function in placenta and cord blood of hepatitis C--seropositive mother-infant dyads.

Hurtado CW, Golden-Mason L, Brocato M, Krull M, Narkewicz MR, Rosen HR.

PLoS One. 2010 Aug 30;5(8):e12232. doi: 10.1371/journal.pone.0012232.

49.

Ophthalmologic complications in children with chronic hepatitis C treated with pegylated interferon.

Narkewicz MR, Rosenthal P, Schwarz KB, Drack A, Margolis T, Repka MX; PEDS-C Study Group.

J Pediatr Gastroenterol Nutr. 2010 Aug;51(2):183-6. doi: 10.1097/MPG.0b013e3181b99cf0.

50.

Fat malabsorption in cystic fibrosis: comparison of quantitative fat assay and a novel assay using fecal lauric/behenic acid.

Dorsey J, Buckley D, Summer S, Jandacek RJ, Rider T, Tso P, Narkewicz MR, Heubi JE.

J Pediatr Gastroenterol Nutr. 2010 Apr;50(4):441-6. doi: 10.1097/MPG.0b013e3181b18308.

Supplemental Content

Loading ...
Support Center